We recently compiled a list of the 8 Best American Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

Pfizer has a diversified portfolio, including successful vaccines and promising new drugs. Read more to see why I upgrade PFE ...

PFIZER INC (PFE) is a large-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 85% based on the firm’s underlying fundamentals and the stock’s valuation.

It is hard to get excited after looking at Pfizer's (NYSE:PFE) recent performance, when its stock has declined 13% ...

Pfizer’s 2024 guidance is upgraded with strong revenue growth. See why PFE stock offers an attractive dividend yield despite ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks ... That's because we believe the present value of its future stream of earnings is what determines the fair value for ...

Pfizer stock (NYSE: PFE) is down 7% in a month, amid rising concerns over the future of vaccines under Robert F. Kennedy Jr. in the new government, given the perception of him being a prominent ...

We also note that PFE has a PEG ratio of 0.71. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. NVO currently ...

Pfizer Inc. (NYSE:PFE) and Alliance Foundation Trials, LLC (AFT) announced results from the Phase 3 PATINA trial. The trial ...